Regulatory Scrutiny on Patanjali Karela Jamun Juice as Claims are Examined under DMR Act
Patanjali Foods Limited has received communication from a state regulatory body regarding promotional and labelling representations for one of its products, Patiwali Karela Jamun Juice. The notice focuses on certain claims made in the product's marketing materials.The Company received the intimation from the Joint Commissioner (Drugs), Food & Drug Administration, Maharashtra State, Nagpur Division, on June 08, 2026. This communication relates to the applicability of Sections 3 and 4 of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 (DMR Act).
The regulatory authority examined promotional and labelling representations associated with Patanjali Karela Jamun Juice and determined that certain claims made may fall within the scope of diseases and conditions listed in the Schedule to the DMR Act.
In response to the findings, the communication issued by the Concerned Authority has directed specific measures concerning the product until concerns are fully addressed. These directives include the recall of the product, discontinuation of its distribution, sale, and supply, as well as withdrawal or modification of certain advertisements and promotional materials. The Company is currently reviewing the contents of the communication with legal advisors and is in the process of formulating an appropriate response.
Preliminary assessments conducted by Patanjali Foods Limited indicate that the receipt of the notice is not expected to have any material financial impact on the business operations of the company. A compliance report must be submitted to the Concerned Authority within 15 days from receiving the original notice.
Key details regarding the regulatory communication are summarized below:
| Detail | Information |
|---|---|
| Regulating Authority | Joint Commissioner (Drugs), Food & Drug Administration, Maharashtra State, Nagpur Division |
| Product Concerned | Patanjali Karela Jamun Juice |
| Regulatory Concern | Certain claims in promotional/labelling representations may fall within the scope of diseases and conditions specified in the Schedule to the DMR Act. |
| Immediate Actions Required by Authority | Recall of product, discontinuation of distribution/sale/supply until concerns are addressed, and withdrawal/modification of certain advertisements. |
| Company Status | Reviewing the content and formulating an appropriate response with legal advisors. |
| Financial Impact (Preliminary) | Not expected to have a material financial impact on the company. |
PATANJALI Stock Price Movement
Patanjali Foods Limited shares today edged higher to close at ₹422.05, gaining 0.57% in post-market trading. The stock saw robust activity, with over 1.07 million shares transacted on the equity in a day that featured volatility near its daily lows.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.